CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Europe Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... Centers, and Others) The Europe concussion market is expected to reach US$ 2,726.9 million by 2028 from US$ 2,162.7 million in 2021. The market is estimated to grow at a CAGR of 3.4% from 2021 ... Read More
-
South and Central America Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... & Clinics, Diagnostic Centers, and Others) The South & Central America concussion market is expected to reach US$ 567.8 million by 2028 from US$ 466.3 million in 2021. The market is estimated to grow at ... Read More
-
Global Brain Computer Interface (BCI) Market 2022-2028
... out a desired action. Implementations of BCIs range from non-invasive (EEG, MEG, EOG, MRI) and partially invasive (ECoG and endovascular) to invasive (microelectrode array), based on how close electrodes get to brain tissue. The main ... Read More
-
Global Brain Health Supplements Market 2022-2028
... cognitive health include boron, choline, CoQ10 and selenium. According to GCBH, 81 percent adults age 50 and older believe that supplements are at least somewhat important for overall health. The global brain health supplements market ... Read More
-
Cannabidiol (CBD) Market Size By Product (Oil, Tinctures, Suppository, Transdermal Patches, Isolates, Tablet, Capsules, Vape Oil, Creams And Roll-On, CBD Inhalers), By Application (Anxiety/Stress, Sleep/Insomnia, Chronic Pain, Migraine, Skin Care, Seizures, Joint Pain & Inflammation, Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Neurological Conditions), By Route of Administration (Oral, Topical, Inhalation, Transdermal Patches, Rectal, Sublingual), By Source (Marijuana, Hemp), By Distribution Channel (Online, Offline {Hospital Pharmacy, Retail Stores}), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, ... Read More
-
Wearable Brain Devices Market Size, Share & Trends Analysis Report By Channel Type (32-Channel Type, 12-Channel Type), By Application (Medical Setting, AR/VR Gaming Settings), By End User, By Region, And Segment Forecasts, 2022 - 2030
... Wearable Brain Devices Market Growth & Trends The global wearable brain devices market size is anticipated to reach USD 668.5 million by 2030, registering a CAGR of 12.33%, according to a new report by Grand ... Read More
-
Antidepressant Drugs Market By Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others); By Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others) And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2030
... Reuptake Inhibitors, and Others) And Region – Global Analysis Of Market Size, Share & Trends For 2019–2020 And Forecasts To 2030 Product Overview Depression impacts a person's thoughts, behavior, feelings, and sense of rationality. Depression ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Post-Traumatic Stress Disorder (PTSD) (Central Nervous System) pipeline landscape. Post-traumatic stress disorder (PTSD) is a ... Read More
-
Cognitive Impairment Associated With Schizophrenia (CIAS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... With Schizophrenia (CIAS) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline landscape. ... Read More
-
Cluster Headache Syndrome (Cluster Headache) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape. Cluster headache is pain that occurs along ... Read More
-
Meniere Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Meniere Disease (Ear Nose Throat Disorders) pipeline landscape. Meniere disease is a disorder of the inner ear that causes ... Read More
-
Medical Tourism Market (Procedure Type: Cardio [Internal Medicine], Cardiothoracic Surgery, Oncology, Fertility Treatments [IVF], Orthopedic Treatment, Dental Treatment, Ophthalmology, Aesthetics/Cosmetic Surgery, Neurology, Regenerative Therapy [Stem Cells], Medical Check-ups [Health Screening], and Others) - Malaysia Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
... Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 Malaysia Medical Tourism Market – Scope of Report TMR’s report on the medical tourism market in Malaysia studies past as well as current growth trends and opportunities ... Read More
-
Epilepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a ... Read More
-
Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape. Traumatic brain injury happens when an external mechanical force ... Read More
-
Drug Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease ... Read More
-
Spinal Muscular Atrophy (SMA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... (ADHD) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape. Attention deficit hyperactivity ... Read More
-
Sedation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sedation (Central Nervous System) pipeline landscape.Sedation is the depression of irritability or agitation. Symptoms include talk slowly and may slur their ... Read More
-
Diabetic Peripheral Neuropathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Diabetic Peripheral Neuropathy (Metabolic Disorders) pipeline landscape. Diabetic neuropathy is nerve damage caused by diabetes. The type ... Read More
-
Sandhoff Disease (Jatzkewitz-Pilz Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Sandhoff Disease (Jatzkewitz-Pilz Syndrome) (Genetic Disorders) pipeline landscape. Sandhoff disease is an inherited lipid storage ... Read More
-
Obsessive-Compulsive Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Obsessive-Compulsive Disorder (Central Nervous System) pipeline landscape. Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that ... Read More
-
Alcohol Addiction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Alcohol Addiction (Central Nervous System) pipeline landscape. Alcohol addiction refers to a psychological and physical dependency on alcohol. Symptoms ... Read More
-
Dementia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Dementia (Central Nervous System) pipeline landscape. Dementia is the loss of mental functions such as thinking, memory, and reasoning that is ... Read More
-
U.S. Contrast Media Market Size, Share & Trends Analysis Report By Type (Gadolinium, Iodinated), By Application (Cardiovascular, Neurological Disorders), By Modality (MRI, X-ray/CT Scan), And Segment Forecasts, 2022 - 2030
... & Trends The U.S. contrast media market is anticipated to reach USD3.36 billion by 2030, registering a CAGR of 4.12% over the forecast period, according to a new report by Grand View Research, Inc. The ... Read More
-
Central Nervous System Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... with a revenue of approximately USD 4,190.84 million in 2021, and it is expected to reach USD 7,113.47 million by 2027. COVID-19 cases across the world had a profound impact on the CNS biomarkers market. ... Read More
Research Assistance
